Ann: Appendix 4C - quarterly, page-29

So many people voicing their disappointment including on Twitter about the latest 4C
Although it wasn’t cash flow positive like I had personally hoped for, it still is a solid quarterly and I’m not sure why others aren’t pleased down this end of the market

Have a look around as July passes by at all the companies with a market cap under $40 million and see what their quarterlies behold in the way of growth/revenue
For those throwing around the word disappointment, I’m hoping you’re prepared to be severely disappointed for the rest of this month, possibly even devastated!

UCM is almost at that point of being a self supporting international growth company in the medical device arena
Their products are being sold at a steady pace, but over the coming couple of years hopefully the sales increase as countries equip their hospitals with Uscom’s life saving devices
Along with all the new products and approvals to help Uscom grow into a much larger co

Low shares on the register
Heavily invested management
Potential for so much blue sky ahead
No debt
Growing revenue year on year
Advanced patented products
Approvals granted and pending (great barrier of entry to competition due to the approval for sale of devices being one of the biggest challenges in the medical realm)

All this for a market cap of $33 million

Take a look around and see how many co’s with this market cap and potential stack up